Long-term survival after R0 resection of thymoma
dc.contributor.author | Koçer B. | |
dc.contributor.author | Kaplan T. | |
dc.contributor.author | Günal N. | |
dc.contributor.author | Koçer B.G. | |
dc.contributor.author | Akkaş Y. | |
dc.contributor.author | Yazkan R. | |
dc.contributor.author | Han S. | |
dc.date.accessioned | 2020-06-25T15:17:57Z | |
dc.date.available | 2020-06-25T15:17:57Z | |
dc.date.issued | 2018 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | Background: The aim of this study was to evaluate the results of R0 resection of thymoma to identify prognostic factors for long-term outcomes. Methods: Data of 62 patients (28 male, 34 female) with a mean age of 47.26 ± 14.42 years, who underwent R0 resection for thymoma and were followed-up between February 2004 and March 2016, were analyzed retrospectively. Results: Eight patients had a video-assisted thoracoscopic thymectomy and 54 had a transsternal extended thymectomy. During a mean follow-up of 128.67 ± 7.95 months, regional recurrence of thymoma was observed in 9 (14.5%) patients. Overall 5- and 10-year survival rates were 85.36% and 78.20%, respectively. The 5- and 10-year survival rates in patients aged < 50 years were significantly better than in those aged ? 50 years (92% and 72% vs. 88% and 39%, p < 0.0001). The 10-year overall survival of patients in Masaoka stage I and II was better than those in stage III (88.9%, 78.4%, 69.8%, respectively, log-rank p < 0.001). The 10-year survival of patients with World Health Organization histological type A, AB, and B1 thymomas was better than those with type B2 and B3 (log-rank test p < 0.001). In multivariate analysis, age < 50 years (p = 0.001), Masaoka stage (p = 0.006), histological type (p = 0.001), and recurrence (p = 0.04) were independent prognostic factors for survival. Conclusion: Our study indicates that age < 50 years, Masaoka stage, histological type, and recurrence are the determinants of survival in surgically resected cases of thymoma. © The Author(s) 2018. | en_US |
dc.identifier.doi | 10.1177/0218492318778634 | |
dc.identifier.endpage | 466 | en_US |
dc.identifier.issn | 02184923 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 29945456 | |
dc.identifier.scopus | 2-s2.0-85049893928 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 461 | en_US |
dc.identifier.uri | https://doi.org/10.1177/0218492318778634 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/2577 | |
dc.identifier.volume | 26 | en_US |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | SAGE Publications Inc. | en_US |
dc.relation.ispartof | Asian Cardiovascular and Thoracic Annals | |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Age groups | en_US |
dc.subject | local | en_US |
dc.subject | Neoplasm recurrence | en_US |
dc.subject | Neoplasm staging | en_US |
dc.subject | Survival rate | en_US |
dc.subject | Thymectomy | en_US |
dc.subject | Thymoma | en_US |
dc.title | Long-term survival after R0 resection of thymoma | en_US |
dc.type | Article |